The coronavirus disease 2019 (COVID‐19) had spread to every continent, with more than 4 million confirmed cases all over the world by May 9, 2020. However, due to lack of awareness of the atypical neu....
2020-07-02
MedComm
Though checkpoint immunotherapy has seemed to achieve much success in clinic application these days, a huge proportion of patients with RAS-driven tumors are still suffering from resistance
2020-06-25
MedComm
Recently, Jian‐Sheng Kang reported a strategy for protecting patients with COVID-19, based on vitamin intervention for cytokine storm. As the global pandemic is still growing, if the vitamin intervent....
2020-06-19
MedComm
There are two kinds of receptor tyrosine kinases --MET and AXL --which are intimately bound up with tumorigenesis and aggressiveness of multiple malignancies. However, the molecular mechanism of MET a....
2020-06-16
MedComm
A closed vascular system is always established by vessel fusion. However, it has been an unsolved mystery that how vessel fusion happened in this process. In this study, Lingmiao Kong et al reported t....
2020-06-09
MedComm
Recently, tumor immunotherapy based on T cells has given patients new hope, however, its problem of low response rate sometimes leads to poor prognosis. That means new strategies sensitizing cancer im....
2020-06-03
MedComm
Cancer immunotherapy has recently drawn much attention for its potentiality on clinic. However, the problem of side effects induced by poor selectivity and high doses still exists. In this review, Lul....
2020-05-27
MedComm
Alzheimer's disease (AD) is one of the most difficult neurological disorders, because there are no means of biomarkers to predict the disease progression, nor is there a cure. Recently, on Nature Medi....
2020-05-22
MedComm
The COVID-19 outbreak has brought challenges to societies around the globe, especially for some special communities. In this article, Qing Zhang et al reviewed some unique challenges the elderly and p....
2020-04-09
MedComm